Evogene Ltd

NASDAQ:EVGN   1:02:00 PM EDT
0.82
+0.06 (+8.03%)
Earnings Announcements

Evogene Reports Second Quarter 2022 Financial Results

Published: 08/31/2022 11:26 GMT
Evogene Ltd (EVGN) - Evogene Reports Second Quarter 2022 Financial Results.
Evogene Ltd - Approximately $35.3 Million in Consolidated Cash, Cash Related Accounts and Marketable Securities As of June 30, 2022.
Revenue is expected to be $0.23 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0.72 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.